Kevin Dewalt, who was blogterviewed by me on his life extension centered life, started his personal blog this week. Excerpts from Kevin’s last post inspired by a lunch with David Gobel, founder and CEO of the Methuselah Foundation: ” The easiest way to simplify something is to look for a reason why it “won’t work”.… Continue reading Kevin Dewalt’s brand new blog
John Schloendorn has a master’s degree in biochemistry at the University of Tuebingen, Germany. Currently he is a graduate student at Arizona State University’s Biodesign Institute, USA. John is heavily involved in the LysoSENS project of the Methuselah Foundation, which aims to remove some intracellular waste products for example via microbe-derived hydrolases targeted to the… Continue reading John Schloendorn, the LysoSENS connection: chat on life extension
Mark Hamalainen is a young PhD student at Cambridge University at the mitochondrion lab of Ian Holt. Mark received a Bachelor of Science Honours degree in biochemistry and computing from Queen’s University in Kingston, Ontario. He also had research training as a visiting scholar at the California Institute of Technology and the Biodesign Institute at… Continue reading Mark Hamalainen, the MitoSENS fellow: blogterview on life extension
Kevin Dewalt is an American technology professional, presently working at a VC. Kevin is a strong life extension supporter. We’ve met online at Baris Karadogan’s blog. I specially liked his “happy argument” for maximum life extension on the psychological level, see answer 3. 1. What is the story of your life extension commitment? When I… Continue reading Kevin Dewalt’s answers: technology professional, lifestyle life extensionist
Dear Reader, if You are stem cell researcher, life scientist, medical doctor, scholar, activist, bloggers, IT professional, venture capitalist, philosopher, economist, politician, decision maker, businessman, biotech- or big pharma manager, plastic surgeon, hairdresser… who support life extension, please answer the questions below and send me to [attilacsordas][at][gmail.com] to get blogterviewed.
Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework
From Market Wire: University of Arkansas for Medical Sciences Biochemist Dr. Craig Cooney today announced that he is entering the competition to win the Methuselah Mouse Prize (Mprize). Cooney is a epigenetics expert, which is the selective silencing of gene activity along specific segments of a DNA strand mainly through the methylation of the nucleotides.… Continue reading American epigenetics expert in Mprize competition for Methuselah mice